Cancer vaccine improvement has obtained a large amount of focus with tiny accomplishment above the a long time, but not too long ago a staff from Tufts University College of Engineering designed a new mRNA cancer vaccine that was analyzed on a mouse product of most cancers. It has accomplished good results in tumor suppression … Read more
Ugur Sahin The founder and CEO of Biontech talks about his successes, visions – and bureaucracy. – (Foto: imago images/Political-Moments) – – – – Mainz The warnings of increasing numbers of corona infections due to the new variant BA.5 are getting louder. However, Biontech boss Ugur Sahin believes that a wave in the summer, if it … Read more
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JYMBEDZS2VCC7HAV3YXVVN4PGE.jpg?fit=%2C&ssl=1)
And review article, published on April 7, 2022 in the journal “Naturedescribes the efforts of science to develop a vaccine against cancer. Today we will make a summary. Although there are already vaccines that can prevent cancer indirectly –against hepatitis B virus (HBV) and human papillomavirus (HPV)–, science has not yet developed vaccines that can … Read more
In the same arm again or would you prefer the other one for a change? Everyone who went for the second, third or even fourth corona vaccination faced this choice. Anyone who always chose the same place for the different vaccine doses could have gained a slight immunological advantage. This is indicated by a new … Read more
Vaccines are the main line of defense against the coronavirus. Another is called medication. Drugs such as “Molnupiravir” from Merck and “Paxlovid” from Pfizer raise hopes. The company has just applied for marketing authorization from the European Medicines Agency (EMA) for Paxlovid. The experts at the EMA would now assess the advantages and risks of … Read more
The efficacy of messenger RNA vaccines Pfizer and Modern decreases after four months to prevent symptomatic SARS-CoV-2 virus infection, study suggests. While these antigens have previously shown 95 and 94.1 efficacy rates percent, respectively, in initial clinical trials, this decreases slightly to 84 percent after the second dose. In the study, published in the New … Read more